Tyndall Capital Partners L P
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed November 27, 2024), Tyndall Capital Partners L P reported 1 stock position worth $379 thousand. Its top holding was Cyclerion Therapeutics at 100.0% of the portfolio. Its holdings were unchanged from Q1 2024.
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001219314
- Portfolio Value
- $379K (Q2 2024)
- SEC Filing
- 0001493152-24-047983 ↗ filed Nov 27, 2024
Holdings Value
Holdings 1 stocks · $379K
| CYCLERION THERAPEUTICS INC | 100.00% | 164,777 | $379K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 0 | $0 | |
| Q4 2025 | 0 | $0 | |
| Q3 2025 | 0 | $0 | |
| Q2 2025 | 1 | $452K | CYCLERION THERAPEUTICS INC |
| Q1 2025 | 1 | $412K | CYCLERION THERAPEUTICS INC |
| Q4 2024 | 1 | $531K | CYCLERION THERAPEUTICS INC |
| Q3 2024 | 1 | $427K | CYCLERION THERAPEUTICS INC |
| Q2 2024Amended | 1 | $379K | CYCLERION THERAPEUTICS INC |
| Q1 2024 | 1 | $527K | CYCLERION THERAPEUTICS INC |